Nanoengineering 2015
DOI: 10.1016/b978-0-444-62747-6.00014-2
|View full text |Cite
|
Sign up to set email alerts
|

Overview of Workplace Exposure to Nanomaterials

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

0
8
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 139 publications
0
8
0
Order By: Relevance
“…It has been reported that the main route of exposure to CeO 2 -NPs is through inhalation, e.g., during occupational exposure when manufacturing CeO 2 -NP-based products [ 31 , 32 ]. Thus, the lung is the main target organ for toxic effects after airborne CeO 2 -NPs [ 31 , 32 , 33 , 34 , 35 ] exposure.…”
Section: Introductionmentioning
confidence: 99%
“…It has been reported that the main route of exposure to CeO 2 -NPs is through inhalation, e.g., during occupational exposure when manufacturing CeO 2 -NP-based products [ 31 , 32 ]. Thus, the lung is the main target organ for toxic effects after airborne CeO 2 -NPs [ 31 , 32 , 33 , 34 , 35 ] exposure.…”
Section: Introductionmentioning
confidence: 99%
“…The physical, chemical, and biological properties of nanoscale materials are significantly, different from those of bulk materials and single atoms or molecules; therefore, different properties of active pharmaceutical ingredients have been modified in such a way [ 14 , 28 , 29 , 30 , 31 , 32 , 33 ]. In biomedical branches, NPs can be used for nanodiagnostics, as nanomaterials for tissue engineering, as drug carriers for specific delivery/targeted biodistribution or controlled release, and as agents/drugs for prevention/treatment of diseases.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, smaller amounts of substances can be used, which allows decreasing dose-dependent toxicity and various side effects. In addition, many formulations also protect bioactive molecules from degradation [ 19 , 20 , 24 , 25 , 28 , 29 , 31 , 34 , 35 , 36 , 37 , 38 , 39 , 40 , 41 , 42 ]. The enhancement of bioavailability could be achieved by the improved solubility of bioactive compounds under gastrointestinal (GI) conditions, their protection from the chemical conditions in the GI tract, and controlled release within the GI tract, or by an improved transfer through the intestinal wall, and the particle size, surface properties, and physical state of the nanomaterials used in food supplements are crucial characteristics affecting their final nutritional value [ 43 ].…”
Section: Introductionmentioning
confidence: 99%
“…The development and exponential growth of nanotechnology-based industries, with an estimation of 6 million workers in 2020 (Roco, 2011), has raised concerns in the potential health risks of exposure to engineered (ENP) or airborne nanoparticles (ANP) (Woskie, 2010). Indeed, over the last years, NP have been regarded as emerging occupational hazards (Dolez and Debia, 2015).…”
Section: Introductionmentioning
confidence: 99%